XBiotech Inc. Quarterly Current Ratio in % from Q3 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
XBiotech Inc. quarterly Current Ratio history and growth rate from Q3 2015 to Q2 2024.
  • XBiotech Inc. Current Ratio for the quarter ending June 30, 2024 was 1.76K %, a 68.2% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 1.76K -3.77K -68.2% Jun 30, 2024
Q1 2024 2.5K -2.11K -45.7% Mar 31, 2024
Q4 2023 4.27K -654 -13.3% Dec 31, 2023
Q3 2023 4.88K -366 -6.98% Sep 30, 2023
Q2 2023 5.53K +223 +4.2% Jun 30, 2023
Q1 2023 4.61K -2.95K -39% Mar 31, 2023
Q4 2022 4.93K -3.33K -40.3% Dec 31, 2022
Q3 2022 5.24K -3.26K -38.3% Sep 30, 2022
Q2 2022 5.31K -2.02K -27.5% Jun 30, 2022
Q1 2022 7.55K +3.25K +75.5% Mar 31, 2022
Q4 2021 8.26K +5.09K +161% Dec 31, 2021
Q3 2021 8.5K +6.86K +420% Sep 30, 2021
Q2 2021 7.33K +5.86K +398% Jun 30, 2021
Q1 2021 4.3K +2.89K +204% Mar 31, 2021
Q4 2020 3.17K +1.96K +162% Dec 31, 2020
Q3 2020 1.64K +501 +44.1% Sep 30, 2020
Q2 2020 1.47K +552 +60.1% Jun 30, 2020
Q1 2020 1.42K +705 +99.2% Mar 31, 2020
Q4 2019 1.21K +309 +34.4% Dec 31, 2019
Q3 2019 1.13K +63.4 +5.91% Sep 30, 2019
Q2 2019 919 -206 -18.3% Jun 30, 2019
Q1 2019 711 -414 -36.8% Mar 31, 2019
Q4 2018 899 -194 -17.7% Dec 31, 2018
Q3 2018 1.07K +225 +26.5% Sep 30, 2018
Q2 2018 1.12K +351 +45.4% Jun 30, 2018
Q1 2018 1.13K +435 +63% Mar 31, 2018
Q4 2017 1.09K +358 +48.7% Dec 31, 2017
Q3 2017 847 -118 -12.2% Sep 30, 2017
Q2 2017 773 -457 -37.1% Jun 30, 2017
Q1 2017 690 -1.25K -64.4% Mar 31, 2017
Q4 2016 735 -1.35K -64.8% Dec 31, 2016
Q3 2016 964 -1.33K -58% Sep 30, 2016
Q2 2016 1.23K Jun 30, 2016
Q1 2016 1.94K Mar 31, 2016
Q4 2015 2.09K Dec 31, 2015
Q3 2015 2.3K Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.